Who are ELYSIUM THERAPEUTICS, INC.'s investors?

ELYSIUM THERAPEUTICS, INC.'s investors include New York Angels.

When was ELYSIUM THERAPEUTICS, INC. founded?

ELYSIUM THERAPEUTICS, INC. was founded in 2015.

Where is ELYSIUM THERAPEUTICS, INC. headquartered?

ELYSIUM THERAPEUTICS, INC. is headquartered in AKRON, Ohio, United States.

What industry is ELYSIUM THERAPEUTICS, INC. in?

ELYSIUM THERAPEUTICS, INC. operates in Biotech, Healthcare.

How many employees does ELYSIUM THERAPEUTICS, INC. have?

ELYSIUM THERAPEUTICS, INC. has 1-10 employees.

ELYSIUM THERAPEUTICS, INC.

Creating safer, more effective solutions for pain management and the opioid crisis

AKRON, United States · Founded 2015

Biotech

Healthcare

Headquarters: AKRON, Ohio
Employees: 1–10
Founded: 2015
Business Model: B2B

Website: elysiumrx.com
Last Round: SeedJan 2026
Rounds: 2

About

Elysium Therapeutics is a pharmaceutical company developing abuse-deterrent and diversion-resistant opioid formulations using their proprietary molecular deactivation (XpiRx) technology. Their SMART product solutions, including O2P (Oral Overdose Protected hydrocodone) and SOOPR (a rescue agent for synthetic opioid overdose), have demonstrated human proof-of-concept. The company has received approximately $16M in NIH SBIR and non-dilutive grant funding.

Summary

ELYSIUM THERAPEUTICS, INC. is a Biotech company based in AKRON, United States, founded in 2015. Its most recent funding was a Seed round in Jan 2026. Investors include New York Angels.